Global Kidney Chip Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Kidney Chip market size was valued at US$ 36.31 million in 2025 and is forecast to a readjusted size of US$ 74.30 million by 2032 with a CAGR of 10.3% during review period.
A Kidney Chip, is an in vitro bioengineered platform that combines human renal cells, microfluidic channels, extracellular matrix, porous membranes, and controlled fluid flow to reproduce selected structural and functional characteristics of the human kidney. Depending on the model, the system may simulate the glomerular filtration barrier, proximal-tubule reabsorption and secretion, distal-tubule transport, collecting-duct function, renal vascular interactions, or communication between multiple nephron segments. The platform is used to study kidney physiology, renal diseases, drug transport, pharmacokinetics, and drug-induced nephrotoxicity under more physiologically relevant conditions than conventional two-dimensional cell culture. The market includes empty microfluidic chips, cell-loaded assay-ready kidney models, organoid-on-chip products, perfusion instruments, pumps, controllers, sensors, imaging and analysis software, culture reagents, customized model-development services, and contract testing. Kidney Chips are research and drug-development tools rather than implantable electronic devices, dialysis products, or artificial kidneys used directly for patient treatment.
Global Kidney Chip market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Kidney Chip market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Kidney Chip market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Kidney Chip market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Chapter 2, to profile the top players of Kidney Chip, with revenue, gross margin, and global market share of Kidney Chip from 2021 to 2026.
Chapter 3, the Kidney Chip competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Kidney Chip market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Kidney Chip.
Chapter 13, to describe Kidney Chip research findings and conclusion.
A Kidney Chip, is an in vitro bioengineered platform that combines human renal cells, microfluidic channels, extracellular matrix, porous membranes, and controlled fluid flow to reproduce selected structural and functional characteristics of the human kidney. Depending on the model, the system may simulate the glomerular filtration barrier, proximal-tubule reabsorption and secretion, distal-tubule transport, collecting-duct function, renal vascular interactions, or communication between multiple nephron segments. The platform is used to study kidney physiology, renal diseases, drug transport, pharmacokinetics, and drug-induced nephrotoxicity under more physiologically relevant conditions than conventional two-dimensional cell culture. The market includes empty microfluidic chips, cell-loaded assay-ready kidney models, organoid-on-chip products, perfusion instruments, pumps, controllers, sensors, imaging and analysis software, culture reagents, customized model-development services, and contract testing. Kidney Chips are research and drug-development tools rather than implantable electronic devices, dialysis products, or artificial kidneys used directly for patient treatment.
Key Findings
- In 2025, global production of Kidney Chip was approximately 22,599 units.
- Microfluidic renal models reproduce transport and barrier functions under controlled flow
- Proximal tubule models remain the most commercially mature product segment
- Drug-induced nephrotoxicity testing represents the principal downstream application
- Pharmaceutical companies and research institutions form the core customer base
- Standardization and regulatory validation will determine future commercial scalability
Market Trends
Kidney Chip development is moving from simple single-cell microchannels toward multicellular, vascularized, organoid-based, and interconnected renal models. Human primary renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, and adult stem-cell-derived kidney organoids are increasingly combined with controlled shear stress and extracellular matrices to improve tissue maturation and transporter expression. Another important trend is the transition from low-throughput customized devices to standardized microplate-compatible formats that support automated liquid handling, high-content imaging, and compound screening. Assay-ready models containing qualified cells and validated protocols are reducing the technical barriers faced by pharmaceutical laboratories. Integrated sensors, real-time imaging, artificial-intelligence-assisted image analysis, and multi-omics measurements are expanding the range of functional readouts. Liver-kidney, gut-liver-kidney, and other multi-organ systems are also gaining attention for studying drug metabolism, systemic exposure, renal clearance, and organ-to-organ toxicity. These developments are gradually shifting Kidney Chips from academic proof-of-concept tools toward repeatable preclinical testing platforms.Market Dynamics
Market development is supported by the pharmaceutical industry’s need for human-relevant preclinical models, but constrained by the difficulty of reproducing the kidney’s complex architecture and functions. Conventional animal models and static cell cultures often provide limited prediction of human renal transport and toxicity, creating demand for more representative alternatives. Regulatory interest in new approach methodologies is improving the strategic position of microphysiological systems, encouraging pharmaceutical companies to evaluate Kidney Chips in internal safety and efficacy programs. However, adoption generally begins through pilot projects because users must compare chip-generated results with animal data, traditional cell assays, clinical biomarkers, and historical compound information. The market therefore combines strong technological potential with cautious commercial implementation. Suppliers must demonstrate not only biological performance but also repeatability across batches, stable cell sourcing, practical workflows, analytical robustness, and cost effectiveness. Partnerships among chip developers, cell suppliers, pharmaceutical companies, contract research organizations, academic laboratories, and regulatory bodies are central to market development.Drivers
The principal driver is the need to identify drug-induced kidney injury earlier and more accurately during pharmaceutical development. Renal toxicity can cause development delays, clinical failures, dosage restrictions, and post-market safety concerns, while conventional models may not adequately reproduce human renal transporters, tubular flow, cell polarity, and interactions between epithelial and vascular tissues. Kidney Chips create controlled environments in which drug exposure, shear stress, reabsorption, secretion, barrier integrity, and biomarker release can be measured dynamically. Growing research on chronic kidney disease, acute kidney injury, diabetic nephropathy, polycystic kidney disease, renal fibrosis, and genetic disorders is also increasing demand for disease-relevant human models. Additional support comes from policies promoting alternatives to animal testing, advances in microfluidics and stem-cell biology, improved access to human renal cells, and growing pharmaceutical investment in microphysiological systems. Together, these factors are expanding Kidney Chip applications from exploratory research toward compound screening, mechanistic toxicology, translational studies, and preclinical decision support.Restraints
Kidney Chip commercialization is limited by biological complexity, high development costs, and the absence of universally accepted validation standards. The human kidney contains multiple specialized cell types and nephron segments that perform filtration, secretion, reabsorption, concentration, endocrine regulation, and vascular exchange. Most current models reproduce only selected functions rather than the complete organ. Cell sourcing is another constraint because primary renal cells may show donor variability and limited expansion, while immortalized or stem-cell-derived cells may not fully achieve adult tissue maturity. Microfluidic operation can introduce bubbles, evaporation, inconsistent flow, material absorption, contamination, and handling difficulties. Customers may also require specialized pumps, imaging systems, technical training, and application-specific analytical methods. Differences in chip geometry, cell type, medium, flow rate, exposure protocol, and endpoint selection make comparisons between platforms difficult. Until standardized reference compounds, performance criteria, and regulatory pathways become more established, many users will continue to apply Kidney Chips as complementary research tools rather than complete replacements for established preclinical methods.Opportunities
Commercial opportunities are strongest in assay-ready renal models that reduce cell-culture complexity and provide validated, reproducible results. Pharmaceutical companies need scalable solutions for nephrotoxicity screening, renal transporter studies, compound ranking, biomarker evaluation, and mechanistic investigation. Disease-specific models using patient-derived cells or induced pluripotent stem cells could support personalized medicine, rare-disease research, and development of therapies for inherited kidney disorders. Multi-organ platforms connecting the kidney with the liver, intestine, heart, muscle, or immune system offer additional opportunities in pharmacokinetics, drug metabolism, systemic toxicity, and organ-to-organ communication. Suppliers can also expand through contract testing, customized model development, data-analysis services, regulatory consulting, software subscriptions, and cell-and-reagent packages. High-throughput plate formats and compatibility with laboratory automation will improve adoption among large pharmaceutical organizations. China, Japan, and South Korea provide meaningful expansion potential due to their pharmaceutical manufacturing, biomedical research, microfluidics capabilities, and policies supporting non-animal testing technologies. Strategic partnerships with contract research organizations and cell suppliers can accelerate commercialization.Challenges
The most important challenge is producing biologically meaningful data with sufficient reproducibility for pharmaceutical and regulatory decision-making. Kidney tissues must maintain appropriate polarity, transporter expression, barrier function, metabolic activity, and response to physiological flow over the required culture period. Small changes in cell source, extracellular matrix, medium composition, chip material, flow rate, or dosing procedure can alter experimental outcomes. Suppliers must also select endpoints that correlate with clinically relevant kidney injury, including functional transport measurements, permeability, morphology, gene expression, and released biomarkers. Scaling from research prototypes to standardized production requires consistent microfabrication, surface treatment, membrane quality, sterilization, packaging, cell loading, and shipping. Another challenge is balancing physiological complexity with throughput and ease of use; highly realistic models may be difficult to operate, while simplified systems may provide insufficient predictive value. Long-term growth will therefore depend on interlaboratory studies, reference-compound testing, transparent performance criteria, standardized data formats, and clearer regulatory acceptance of Kidney Chip evidence.Industry Chain Analysis
The upstream industry comprises microfluidic polymers and glass, porous membranes, extracellular matrices, coatings, human renal cells, stem cells, organoids, culture media, growth factors, pumps, valves, tubing, sensors, imaging systems, and laboratory automation equipment. Upstream quality directly influences cell viability, fluid control, optical performance, compound absorption, and experimental reproducibility. Midstream companies design and manufacture chips, integrate perfusion hardware, establish renal cell models, optimize culture protocols, develop software, validate biological functions, and provide assay-ready products or testing services. Their competitiveness depends on the combined capabilities of microengineering, cell biology, tissue engineering, pharmacology, and data analysis. Downstream customers include pharmaceutical and biotechnology companies, contract research organizations, universities, hospitals, government laboratories, chemical and cosmetics companies, and regulatory research institutions. Products are distributed through direct technical sales, scientific-instrument distributors, collaborative development agreements, and contract-service models. Training, installation, application development, data interpretation, maintenance, and consumable supply form an important service layer throughout the industry chain.Value Chain Analysis
The physical microfluidic chip represents only one component of the Kidney Chip value chain. Higher value is generally created through biological model construction, qualified cell sourcing, extracellular-matrix optimization, perfusion control, functional validation, assay design, software analysis, and interpretation of translational data. Empty chips and general-purpose perfusion devices provide flexibility for research users but require substantial in-house expertise. Cell-loaded and assay-ready products command greater strategic value because they reduce model-establishment time, improve batch consistency, and allow users to focus on compound testing. Customized development services add further value by adapting models to specific renal diseases, drug mechanisms, biomarkers, or regulatory questions. Data services and application support become increasingly important as customers seek to connect chip results with animal studies, clinical biomarkers, pharmacokinetic models, and decision-making systems. Recurring revenue can be generated from disposable chips, cells, media, reagents, calibration, maintenance, software, and contract assays. Companies controlling both engineering and biological validation are generally better positioned to capture value across the product lifecycle.Segment Insights
By simulated renal structure, Kidney Chips can be divided into glomerulus-on-chip, proximal-tubule-on-chip, distal-tubule or collecting-duct models, and integrated nephron or multi-organ systems. Proximal-tubule models currently represent the most commercially developed segment because they support nephrotoxicity, transporter, secretion, and reabsorption studies. By technical architecture, products include membrane-separated dual-channel chips, matrix-embedded three-dimensional tubular models, organoid-on-chip systems, vascularized models, and bioprinted renal chips. By product form, the market can be classified into empty chips and consumables, cell-loaded assay-ready models, instruments and perfusion systems, and customized testing services. By cell source, models use primary human renal cells, immortalized cell lines, induced pluripotent stem-cell-derived cells, or adult stem-cell-derived organoids. Major application segments include drug-induced nephrotoxicity testing, renal disease modeling, drug transport and clearance analysis, pharmacokinetic and ADME studies, and personalized medicine. Product selection depends on biological complexity, throughput, reproducibility, operating difficulty, and required analytical endpoints.Downstream Market Opportunities
Drug-induced nephrotoxicity testing represents the principal downstream opportunity because pharmaceutical companies need earlier identification of compounds that damage glomerular, tubular, vascular, or interstitial tissues. Kidney Chips can support compound ranking, dose-response analysis, biomarker evaluation, and investigation of renal transport mechanisms. Disease modeling provides another important opportunity, covering acute kidney injury, chronic kidney disease, diabetic nephropathy, polycystic kidney disease, fibrosis, infection, and inherited disorders. Renal transport and clearance studies can improve understanding of drug secretion, reabsorption, metabolite handling, and drug-drug interactions. Multi-organ applications enable analysis of metabolites generated by the liver, substances absorbed through the intestine, and systemic toxicity involving the kidney and other tissues. Patient-derived cells and kidney organoids create longer-term opportunities in precision medicine and individualized treatment selection. Pharmaceutical companies, biotechnology firms, contract research organizations, academic institutions, and regulatory laboratories are the core customers, while chemical, cosmetics, food, and environmental-safety organizations represent additional application areas for renal toxicity assessment.Regional Insights
North America is an important center for Kidney Chip commercialization, pharmaceutical adoption, academic research, and regulatory collaboration, supported by companies such as Emulate, Nortis, Hesperos, and Creative Biolabs. Europe also has a strong industrial base in organ-on-a-chip platforms, with MIMETAS, TissUse, CN Bio, Kirkstall, BEOnChip, InSphero, and Fluigent participating in kidney, multi-organ, perfusion, or enabling-system development. The region benefits from established pharmaceutical research, microfluidics expertise, and policies encouraging non-animal methods. Asia-Pacific is developing rapidly as China, Japan, and South Korea expand investment in organoid technologies, microphysiological systems, drug-safety evaluation, and domestic scientific instruments. Beijing Daxiang Biotech is active in organoid-chip models in China, while Nanosystems Japan and EDmicBio participate in microfluidic or three-dimensional organ-chip development in Japan and South Korea. Regional growth will depend on standardized validation, local cell resources, pharmaceutical partnerships, regulatory acceptance, distributor capabilities, and technical-service infrastructure.Competitive Landscape Analysis
The competitive landscape includes dedicated Kidney Chip suppliers, broad organ-on-a-chip platform companies, perfusion-system manufacturers, microfluidic-device producers, and contract model-development providers. Emulate offers a validated Kidney-Chip model, while MIMETAS provides perfused kidney models and kidney organoid tubules based on its OrganoPlate platform. Nortis is recognized for proximal-tubule chips, and TissUse develops kidney-containing multi-organ systems. CN Bio and Hesperos provide platforms capable of incorporating renal tissues into single- or multi-organ studies. Creative Biolabs offers customized Kidney Chip development services, while Kirkstall, BEOnChip, InSphero, Fluigent, and Microfluidics Innovation Center provide adaptable organ-chip, perfusion, or kidney-model solutions. In Asia, Beijing Daxiang Biotech, Nanosystems Japan, and EDmicBio represent emerging participants in organoid-chip, microfluidic fabrication, and three-dimensional organ-chip technologies. Competition centers on biological relevance, validated renal functions, throughput, ease of operation, cell quality, automation, data analysis, regulatory credibility, and application support rather than on chip manufacturing capacity alone.Report Scope
This report is a detailed and comprehensive analysis for global Kidney Chip market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.Key Features:
Global Kidney Chip market size and forecasts, in consumption value ($ Million), 2021-2032Global Kidney Chip market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Kidney Chip market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Kidney Chip market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Kidney Chip
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Kidney Chip market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
- Glomerulus-on-a-Chip
- Renal Tubule-on-a-Chip
- Others
Market segment by Channel
- Single-Channel
- Dual-Channel
Market segment by Source
- Primary Human Cell-Based Type
- Immortalized Cell Line-Based Type
- Stem Cell & Organoid-Based Type
Market segment by Application
- Hospitals
- Research Institutions
- Universities
- Others
Market segment by players, this report covers
- Emulate
- Mimetas
- TissUse
- Valo Health
- CN Bio Innovations
- Draper Laboratory
- Nortis
- Xona Microfluidics
- SynVivo
- Beijing Daxiang Biotech
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Kidney Chip product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Kidney Chip, with revenue, gross margin, and global market share of Kidney Chip from 2021 to 2026.
Chapter 3, the Kidney Chip competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Kidney Chip market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Kidney Chip.
Chapter 13, to describe Kidney Chip research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Kidney Chip by Type
1.3.1 Overview: Global Kidney Chip Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Kidney Chip Consumption Value Market Share by Type in 2025
1.3.3 Glomerulus-on-a-Chip
1.3.4 Renal Tubule-on-a-Chip
1.3.5 Others
1.4 Classification of Kidney Chip by Channel
1.4.1 Overview: Global Kidney Chip Market Size by Channel: 2021 Versus 2025 Versus 2032
1.4.2 Global Kidney Chip Consumption Value Market Share by Channel in 2025
1.4.3 Single-Channel
1.4.4 Dual-Channel
1.5 Classification of Kidney Chip by Source
1.5.1 Overview: Global Kidney Chip Market Size by Source: 2021 Versus 2025 Versus 2032
1.5.2 Global Kidney Chip Consumption Value Market Share by Source in 2025
1.5.3 Primary Human Cell-Based Type
1.5.4 Immortalized Cell Line-Based Type
1.5.5 Stem Cell & Organoid-Based Type
1.6 Global Kidney Chip Market by Application
1.6.1 Overview: Global Kidney Chip Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals
1.6.3 Research Institutions
1.6.4 Universities
1.6.5 Others
1.7 Global Kidney Chip Market Size & Forecast
1.8 Global Kidney Chip Market Size and Forecast by Region
1.8.1 Global Kidney Chip Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Kidney Chip Market Size by Region, (2021-2032)
1.8.3 North America Kidney Chip Market Size and Prospect (2021-2032)
1.8.4 Europe Kidney Chip Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Kidney Chip Market Size and Prospect (2021-2032)
1.8.6 South America Kidney Chip Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Kidney Chip Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Emulate
2.1.1 Emulate Details
2.1.2 Emulate Major Business
2.1.3 Emulate Kidney Chip Product and Solutions
2.1.4 Emulate Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Emulate Recent Developments and Future Plans
2.2 Mimetas
2.2.1 Mimetas Details
2.2.2 Mimetas Major Business
2.2.3 Mimetas Kidney Chip Product and Solutions
2.2.4 Mimetas Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Mimetas Recent Developments and Future Plans
2.3 TissUse
2.3.1 TissUse Details
2.3.2 TissUse Major Business
2.3.3 TissUse Kidney Chip Product and Solutions
2.3.4 TissUse Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 TissUse Recent Developments and Future Plans
2.4 Valo Health
2.4.1 Valo Health Details
2.4.2 Valo Health Major Business
2.4.3 Valo Health Kidney Chip Product and Solutions
2.4.4 Valo Health Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Valo Health Recent Developments and Future Plans
2.5 CN Bio Innovations
2.5.1 CN Bio Innovations Details
2.5.2 CN Bio Innovations Major Business
2.5.3 CN Bio Innovations Kidney Chip Product and Solutions
2.5.4 CN Bio Innovations Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CN Bio Innovations Recent Developments and Future Plans
2.6 Draper Laboratory
2.6.1 Draper Laboratory Details
2.6.2 Draper Laboratory Major Business
2.6.3 Draper Laboratory Kidney Chip Product and Solutions
2.6.4 Draper Laboratory Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Draper Laboratory Recent Developments and Future Plans
2.7 Nortis
2.7.1 Nortis Details
2.7.2 Nortis Major Business
2.7.3 Nortis Kidney Chip Product and Solutions
2.7.4 Nortis Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nortis Recent Developments and Future Plans
2.8 Xona Microfluidics
2.8.1 Xona Microfluidics Details
2.8.2 Xona Microfluidics Major Business
2.8.3 Xona Microfluidics Kidney Chip Product and Solutions
2.8.4 Xona Microfluidics Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Xona Microfluidics Recent Developments and Future Plans
2.9 SynVivo
2.9.1 SynVivo Details
2.9.2 SynVivo Major Business
2.9.3 SynVivo Kidney Chip Product and Solutions
2.9.4 SynVivo Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 SynVivo Recent Developments and Future Plans
2.10 Beijing Daxiang Biotech
2.10.1 Beijing Daxiang Biotech Details
2.10.2 Beijing Daxiang Biotech Major Business
2.10.3 Beijing Daxiang Biotech Kidney Chip Product and Solutions
2.10.4 Beijing Daxiang Biotech Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Beijing Daxiang Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Kidney Chip Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Kidney Chip by Company Revenue
3.2.2 Top 3 Kidney Chip Players Market Share in 2025
3.2.3 Top 6 Kidney Chip Players Market Share in 2025
3.3 Kidney Chip Market: Overall Company Footprint Analysis
3.3.1 Kidney Chip Market: Region Footprint
3.3.2 Kidney Chip Market: Company Product Type Footprint
3.3.3 Kidney Chip Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Kidney Chip Consumption Value and Market Share by Type (2021-2026)
4.2 Global Kidney Chip Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Kidney Chip Consumption Value Market Share by Application (2021-2026)
5.2 Global Kidney Chip Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Kidney Chip Consumption Value by Type (2021-2032)
6.2 North America Kidney Chip Market Size by Application (2021-2032)
6.3 North America Kidney Chip Market Size by Country
6.3.1 North America Kidney Chip Consumption Value by Country (2021-2032)
6.3.2 United States Kidney Chip Market Size and Forecast (2021-2032)
6.3.3 Canada Kidney Chip Market Size and Forecast (2021-2032)
6.3.4 Mexico Kidney Chip Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Kidney Chip Consumption Value by Type (2021-2032)
7.2 Europe Kidney Chip Consumption Value by Application (2021-2032)
7.3 Europe Kidney Chip Market Size by Country
7.3.1 Europe Kidney Chip Consumption Value by Country (2021-2032)
7.3.2 Germany Kidney Chip Market Size and Forecast (2021-2032)
7.3.3 France Kidney Chip Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Kidney Chip Market Size and Forecast (2021-2032)
7.3.5 Russia Kidney Chip Market Size and Forecast (2021-2032)
7.3.6 Italy Kidney Chip Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Kidney Chip Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Kidney Chip Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Kidney Chip Market Size by Region
8.3.1 Asia-Pacific Kidney Chip Consumption Value by Region (2021-2032)
8.3.2 China Kidney Chip Market Size and Forecast (2021-2032)
8.3.3 Japan Kidney Chip Market Size and Forecast (2021-2032)
8.3.4 South Korea Kidney Chip Market Size and Forecast (2021-2032)
8.3.5 India Kidney Chip Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Kidney Chip Market Size and Forecast (2021-2032)
8.3.7 Australia Kidney Chip Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Kidney Chip Consumption Value by Type (2021-2032)
9.2 South America Kidney Chip Consumption Value by Application (2021-2032)
9.3 South America Kidney Chip Market Size by Country
9.3.1 South America Kidney Chip Consumption Value by Country (2021-2032)
9.3.2 Brazil Kidney Chip Market Size and Forecast (2021-2032)
9.3.3 Argentina Kidney Chip Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Kidney Chip Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Kidney Chip Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Kidney Chip Market Size by Country
10.3.1 Middle East & Africa Kidney Chip Consumption Value by Country (2021-2032)
10.3.2 Turkey Kidney Chip Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Kidney Chip Market Size and Forecast (2021-2032)
10.3.4 UAE Kidney Chip Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Kidney Chip Market Drivers
11.2 Kidney Chip Market Restraints
11.3 Kidney Chip Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Kidney Chip Industry Chain
12.2 Kidney Chip Upstream Analysis
12.3 Kidney Chip Midstream Analysis
12.4 Kidney Chip Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Kidney Chip by Type
1.3.1 Overview: Global Kidney Chip Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Kidney Chip Consumption Value Market Share by Type in 2025
1.3.3 Glomerulus-on-a-Chip
1.3.4 Renal Tubule-on-a-Chip
1.3.5 Others
1.4 Classification of Kidney Chip by Channel
1.4.1 Overview: Global Kidney Chip Market Size by Channel: 2021 Versus 2025 Versus 2032
1.4.2 Global Kidney Chip Consumption Value Market Share by Channel in 2025
1.4.3 Single-Channel
1.4.4 Dual-Channel
1.5 Classification of Kidney Chip by Source
1.5.1 Overview: Global Kidney Chip Market Size by Source: 2021 Versus 2025 Versus 2032
1.5.2 Global Kidney Chip Consumption Value Market Share by Source in 2025
1.5.3 Primary Human Cell-Based Type
1.5.4 Immortalized Cell Line-Based Type
1.5.5 Stem Cell & Organoid-Based Type
1.6 Global Kidney Chip Market by Application
1.6.1 Overview: Global Kidney Chip Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals
1.6.3 Research Institutions
1.6.4 Universities
1.6.5 Others
1.7 Global Kidney Chip Market Size & Forecast
1.8 Global Kidney Chip Market Size and Forecast by Region
1.8.1 Global Kidney Chip Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Kidney Chip Market Size by Region, (2021-2032)
1.8.3 North America Kidney Chip Market Size and Prospect (2021-2032)
1.8.4 Europe Kidney Chip Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Kidney Chip Market Size and Prospect (2021-2032)
1.8.6 South America Kidney Chip Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Kidney Chip Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Emulate
2.1.1 Emulate Details
2.1.2 Emulate Major Business
2.1.3 Emulate Kidney Chip Product and Solutions
2.1.4 Emulate Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Emulate Recent Developments and Future Plans
2.2 Mimetas
2.2.1 Mimetas Details
2.2.2 Mimetas Major Business
2.2.3 Mimetas Kidney Chip Product and Solutions
2.2.4 Mimetas Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Mimetas Recent Developments and Future Plans
2.3 TissUse
2.3.1 TissUse Details
2.3.2 TissUse Major Business
2.3.3 TissUse Kidney Chip Product and Solutions
2.3.4 TissUse Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 TissUse Recent Developments and Future Plans
2.4 Valo Health
2.4.1 Valo Health Details
2.4.2 Valo Health Major Business
2.4.3 Valo Health Kidney Chip Product and Solutions
2.4.4 Valo Health Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Valo Health Recent Developments and Future Plans
2.5 CN Bio Innovations
2.5.1 CN Bio Innovations Details
2.5.2 CN Bio Innovations Major Business
2.5.3 CN Bio Innovations Kidney Chip Product and Solutions
2.5.4 CN Bio Innovations Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 CN Bio Innovations Recent Developments and Future Plans
2.6 Draper Laboratory
2.6.1 Draper Laboratory Details
2.6.2 Draper Laboratory Major Business
2.6.3 Draper Laboratory Kidney Chip Product and Solutions
2.6.4 Draper Laboratory Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Draper Laboratory Recent Developments and Future Plans
2.7 Nortis
2.7.1 Nortis Details
2.7.2 Nortis Major Business
2.7.3 Nortis Kidney Chip Product and Solutions
2.7.4 Nortis Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nortis Recent Developments and Future Plans
2.8 Xona Microfluidics
2.8.1 Xona Microfluidics Details
2.8.2 Xona Microfluidics Major Business
2.8.3 Xona Microfluidics Kidney Chip Product and Solutions
2.8.4 Xona Microfluidics Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Xona Microfluidics Recent Developments and Future Plans
2.9 SynVivo
2.9.1 SynVivo Details
2.9.2 SynVivo Major Business
2.9.3 SynVivo Kidney Chip Product and Solutions
2.9.4 SynVivo Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 SynVivo Recent Developments and Future Plans
2.10 Beijing Daxiang Biotech
2.10.1 Beijing Daxiang Biotech Details
2.10.2 Beijing Daxiang Biotech Major Business
2.10.3 Beijing Daxiang Biotech Kidney Chip Product and Solutions
2.10.4 Beijing Daxiang Biotech Kidney Chip Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Beijing Daxiang Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Kidney Chip Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Kidney Chip by Company Revenue
3.2.2 Top 3 Kidney Chip Players Market Share in 2025
3.2.3 Top 6 Kidney Chip Players Market Share in 2025
3.3 Kidney Chip Market: Overall Company Footprint Analysis
3.3.1 Kidney Chip Market: Region Footprint
3.3.2 Kidney Chip Market: Company Product Type Footprint
3.3.3 Kidney Chip Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Kidney Chip Consumption Value and Market Share by Type (2021-2026)
4.2 Global Kidney Chip Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Kidney Chip Consumption Value Market Share by Application (2021-2026)
5.2 Global Kidney Chip Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Kidney Chip Consumption Value by Type (2021-2032)
6.2 North America Kidney Chip Market Size by Application (2021-2032)
6.3 North America Kidney Chip Market Size by Country
6.3.1 North America Kidney Chip Consumption Value by Country (2021-2032)
6.3.2 United States Kidney Chip Market Size and Forecast (2021-2032)
6.3.3 Canada Kidney Chip Market Size and Forecast (2021-2032)
6.3.4 Mexico Kidney Chip Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Kidney Chip Consumption Value by Type (2021-2032)
7.2 Europe Kidney Chip Consumption Value by Application (2021-2032)
7.3 Europe Kidney Chip Market Size by Country
7.3.1 Europe Kidney Chip Consumption Value by Country (2021-2032)
7.3.2 Germany Kidney Chip Market Size and Forecast (2021-2032)
7.3.3 France Kidney Chip Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Kidney Chip Market Size and Forecast (2021-2032)
7.3.5 Russia Kidney Chip Market Size and Forecast (2021-2032)
7.3.6 Italy Kidney Chip Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Kidney Chip Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Kidney Chip Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Kidney Chip Market Size by Region
8.3.1 Asia-Pacific Kidney Chip Consumption Value by Region (2021-2032)
8.3.2 China Kidney Chip Market Size and Forecast (2021-2032)
8.3.3 Japan Kidney Chip Market Size and Forecast (2021-2032)
8.3.4 South Korea Kidney Chip Market Size and Forecast (2021-2032)
8.3.5 India Kidney Chip Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Kidney Chip Market Size and Forecast (2021-2032)
8.3.7 Australia Kidney Chip Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Kidney Chip Consumption Value by Type (2021-2032)
9.2 South America Kidney Chip Consumption Value by Application (2021-2032)
9.3 South America Kidney Chip Market Size by Country
9.3.1 South America Kidney Chip Consumption Value by Country (2021-2032)
9.3.2 Brazil Kidney Chip Market Size and Forecast (2021-2032)
9.3.3 Argentina Kidney Chip Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Kidney Chip Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Kidney Chip Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Kidney Chip Market Size by Country
10.3.1 Middle East & Africa Kidney Chip Consumption Value by Country (2021-2032)
10.3.2 Turkey Kidney Chip Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Kidney Chip Market Size and Forecast (2021-2032)
10.3.4 UAE Kidney Chip Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Kidney Chip Market Drivers
11.2 Kidney Chip Market Restraints
11.3 Kidney Chip Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Kidney Chip Industry Chain
12.2 Kidney Chip Upstream Analysis
12.3 Kidney Chip Midstream Analysis
12.4 Kidney Chip Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Kidney Chip Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Kidney Chip Consumption Value by Channel, (USD Million), 2021 & 2025 & 2032
Table 3. Global Kidney Chip Consumption Value by Source, (USD Million), 2021 & 2025 & 2032
Table 4. Global Kidney Chip Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Kidney Chip Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Kidney Chip Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Emulate Company Information, Head Office, and Major Competitors
Table 8. Emulate Major Business
Table 9. Emulate Kidney Chip Product and Solutions
Table 10. Emulate Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Emulate Recent Developments and Future Plans
Table 12. Mimetas Company Information, Head Office, and Major Competitors
Table 13. Mimetas Major Business
Table 14. Mimetas Kidney Chip Product and Solutions
Table 15. Mimetas Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Mimetas Recent Developments and Future Plans
Table 17. TissUse Company Information, Head Office, and Major Competitors
Table 18. TissUse Major Business
Table 19. TissUse Kidney Chip Product and Solutions
Table 20. TissUse Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Valo Health Company Information, Head Office, and Major Competitors
Table 22. Valo Health Major Business
Table 23. Valo Health Kidney Chip Product and Solutions
Table 24. Valo Health Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Valo Health Recent Developments and Future Plans
Table 26. CN Bio Innovations Company Information, Head Office, and Major Competitors
Table 27. CN Bio Innovations Major Business
Table 28. CN Bio Innovations Kidney Chip Product and Solutions
Table 29. CN Bio Innovations Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. CN Bio Innovations Recent Developments and Future Plans
Table 31. Draper Laboratory Company Information, Head Office, and Major Competitors
Table 32. Draper Laboratory Major Business
Table 33. Draper Laboratory Kidney Chip Product and Solutions
Table 34. Draper Laboratory Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Draper Laboratory Recent Developments and Future Plans
Table 36. Nortis Company Information, Head Office, and Major Competitors
Table 37. Nortis Major Business
Table 38. Nortis Kidney Chip Product and Solutions
Table 39. Nortis Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Nortis Recent Developments and Future Plans
Table 41. Xona Microfluidics Company Information, Head Office, and Major Competitors
Table 42. Xona Microfluidics Major Business
Table 43. Xona Microfluidics Kidney Chip Product and Solutions
Table 44. Xona Microfluidics Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Xona Microfluidics Recent Developments and Future Plans
Table 46. SynVivo Company Information, Head Office, and Major Competitors
Table 47. SynVivo Major Business
Table 48. SynVivo Kidney Chip Product and Solutions
Table 49. SynVivo Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. SynVivo Recent Developments and Future Plans
Table 51. Beijing Daxiang Biotech Company Information, Head Office, and Major Competitors
Table 52. Beijing Daxiang Biotech Major Business
Table 53. Beijing Daxiang Biotech Kidney Chip Product and Solutions
Table 54. Beijing Daxiang Biotech Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Beijing Daxiang Biotech Recent Developments and Future Plans
Table 56. Global Kidney Chip Revenue (USD Million) by Players (2021-2026)
Table 57. Global Kidney Chip Revenue Share by Players (2021-2026)
Table 58. Breakdown of Kidney Chip by Company Type (Tier 1, Tier 2, and Tier 3)
Table 59. Market Position of Players in Kidney Chip, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 60. Head Office of Key Kidney Chip Players
Table 61. Kidney Chip Market: Company Product Type Footprint
Table 62. Kidney Chip Market: Company Product Application Footprint
Table 63. Kidney Chip New Market Entrants and Barriers to Market Entry
Table 64. Kidney Chip Mergers, Acquisition, Agreements, and Collaborations
Table 65. Global Kidney Chip Consumption Value (USD Million) by Type (2021-2026)
Table 66. Global Kidney Chip Consumption Value Share by Type (2021-2026)
Table 67. Global Kidney Chip Consumption Value Forecast by Type (2027-2032)
Table 68. Global Kidney Chip Consumption Value by Application (2021-2026)
Table 69. Global Kidney Chip Consumption Value Forecast by Application (2027-2032)
Table 70. North America Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 71. North America Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 72. North America Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 73. North America Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 74. North America Kidney Chip Consumption Value by Country (2021-2026) & (USD Million)
Table 75. North America Kidney Chip Consumption Value by Country (2027-2032) & (USD Million)
Table 76. Europe Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 77. Europe Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 78. Europe Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 79. Europe Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 80. Europe Kidney Chip Consumption Value by Country (2021-2026) & (USD Million)
Table 81. Europe Kidney Chip Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Asia-Pacific Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Asia-Pacific Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Asia-Pacific Kidney Chip Consumption Value by Region (2021-2026) & (USD Million)
Table 87. Asia-Pacific Kidney Chip Consumption Value by Region (2027-2032) & (USD Million)
Table 88. South America Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 89. South America Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 90. South America Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 91. South America Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 92. South America Kidney Chip Consumption Value by Country (2021-2026) & (USD Million)
Table 93. South America Kidney Chip Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Middle East & Africa Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 96. Middle East & Africa Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 98. Middle East & Africa Kidney Chip Consumption Value by Country (2021-2026) & (USD Million)
Table 99. Middle East & Africa Kidney Chip Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Global Key Players of Kidney Chip Upstream (Raw Materials)
Table 101. Global Kidney Chip Typical Customers
Table 1. Global Kidney Chip Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Kidney Chip Consumption Value by Channel, (USD Million), 2021 & 2025 & 2032
Table 3. Global Kidney Chip Consumption Value by Source, (USD Million), 2021 & 2025 & 2032
Table 4. Global Kidney Chip Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Kidney Chip Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Kidney Chip Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Emulate Company Information, Head Office, and Major Competitors
Table 8. Emulate Major Business
Table 9. Emulate Kidney Chip Product and Solutions
Table 10. Emulate Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Emulate Recent Developments and Future Plans
Table 12. Mimetas Company Information, Head Office, and Major Competitors
Table 13. Mimetas Major Business
Table 14. Mimetas Kidney Chip Product and Solutions
Table 15. Mimetas Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Mimetas Recent Developments and Future Plans
Table 17. TissUse Company Information, Head Office, and Major Competitors
Table 18. TissUse Major Business
Table 19. TissUse Kidney Chip Product and Solutions
Table 20. TissUse Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Valo Health Company Information, Head Office, and Major Competitors
Table 22. Valo Health Major Business
Table 23. Valo Health Kidney Chip Product and Solutions
Table 24. Valo Health Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Valo Health Recent Developments and Future Plans
Table 26. CN Bio Innovations Company Information, Head Office, and Major Competitors
Table 27. CN Bio Innovations Major Business
Table 28. CN Bio Innovations Kidney Chip Product and Solutions
Table 29. CN Bio Innovations Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. CN Bio Innovations Recent Developments and Future Plans
Table 31. Draper Laboratory Company Information, Head Office, and Major Competitors
Table 32. Draper Laboratory Major Business
Table 33. Draper Laboratory Kidney Chip Product and Solutions
Table 34. Draper Laboratory Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Draper Laboratory Recent Developments and Future Plans
Table 36. Nortis Company Information, Head Office, and Major Competitors
Table 37. Nortis Major Business
Table 38. Nortis Kidney Chip Product and Solutions
Table 39. Nortis Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Nortis Recent Developments and Future Plans
Table 41. Xona Microfluidics Company Information, Head Office, and Major Competitors
Table 42. Xona Microfluidics Major Business
Table 43. Xona Microfluidics Kidney Chip Product and Solutions
Table 44. Xona Microfluidics Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Xona Microfluidics Recent Developments and Future Plans
Table 46. SynVivo Company Information, Head Office, and Major Competitors
Table 47. SynVivo Major Business
Table 48. SynVivo Kidney Chip Product and Solutions
Table 49. SynVivo Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. SynVivo Recent Developments and Future Plans
Table 51. Beijing Daxiang Biotech Company Information, Head Office, and Major Competitors
Table 52. Beijing Daxiang Biotech Major Business
Table 53. Beijing Daxiang Biotech Kidney Chip Product and Solutions
Table 54. Beijing Daxiang Biotech Kidney Chip Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Beijing Daxiang Biotech Recent Developments and Future Plans
Table 56. Global Kidney Chip Revenue (USD Million) by Players (2021-2026)
Table 57. Global Kidney Chip Revenue Share by Players (2021-2026)
Table 58. Breakdown of Kidney Chip by Company Type (Tier 1, Tier 2, and Tier 3)
Table 59. Market Position of Players in Kidney Chip, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 60. Head Office of Key Kidney Chip Players
Table 61. Kidney Chip Market: Company Product Type Footprint
Table 62. Kidney Chip Market: Company Product Application Footprint
Table 63. Kidney Chip New Market Entrants and Barriers to Market Entry
Table 64. Kidney Chip Mergers, Acquisition, Agreements, and Collaborations
Table 65. Global Kidney Chip Consumption Value (USD Million) by Type (2021-2026)
Table 66. Global Kidney Chip Consumption Value Share by Type (2021-2026)
Table 67. Global Kidney Chip Consumption Value Forecast by Type (2027-2032)
Table 68. Global Kidney Chip Consumption Value by Application (2021-2026)
Table 69. Global Kidney Chip Consumption Value Forecast by Application (2027-2032)
Table 70. North America Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 71. North America Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 72. North America Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 73. North America Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 74. North America Kidney Chip Consumption Value by Country (2021-2026) & (USD Million)
Table 75. North America Kidney Chip Consumption Value by Country (2027-2032) & (USD Million)
Table 76. Europe Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 77. Europe Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 78. Europe Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 79. Europe Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 80. Europe Kidney Chip Consumption Value by Country (2021-2026) & (USD Million)
Table 81. Europe Kidney Chip Consumption Value by Country (2027-2032) & (USD Million)
Table 82. Asia-Pacific Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Asia-Pacific Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 86. Asia-Pacific Kidney Chip Consumption Value by Region (2021-2026) & (USD Million)
Table 87. Asia-Pacific Kidney Chip Consumption Value by Region (2027-2032) & (USD Million)
Table 88. South America Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 89. South America Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 90. South America Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 91. South America Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 92. South America Kidney Chip Consumption Value by Country (2021-2026) & (USD Million)
Table 93. South America Kidney Chip Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Middle East & Africa Kidney Chip Consumption Value by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Kidney Chip Consumption Value by Type (2027-2032) & (USD Million)
Table 96. Middle East & Africa Kidney Chip Consumption Value by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Kidney Chip Consumption Value by Application (2027-2032) & (USD Million)
Table 98. Middle East & Africa Kidney Chip Consumption Value by Country (2021-2026) & (USD Million)
Table 99. Middle East & Africa Kidney Chip Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Global Key Players of Kidney Chip Upstream (Raw Materials)
Table 101. Global Kidney Chip Typical Customers
LIST OF FIGURES
Figure 1. Kidney Chip Picture
Figure 2. Global Kidney Chip Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Kidney Chip Consumption Value Market Share by Type in 2025
Figure 4. Glomerulus-on-a-Chip
Figure 5. Renal Tubule-on-a-Chip
Figure 6. Others
Figure 7. Global Kidney Chip Consumption Value by Channel, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Kidney Chip Consumption Value Market Share by Channel in 2025
Figure 9. Single-Channel
Figure 10. Dual-Channel
Figure 11. Global Kidney Chip Consumption Value by Source, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Kidney Chip Consumption Value Market Share by Source in 2025
Figure 13. Primary Human Cell-Based Type
Figure 14. Immortalized Cell Line-Based Type
Figure 15. Stem Cell & Organoid-Based Type
Figure 16. Global Kidney Chip Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Kidney Chip Consumption Value Market Share by Application in 2025
Figure 18. Hospitals Picture
Figure 19. Research Institutions Picture
Figure 20. Universities Picture
Figure 21. Others Picture
Figure 22. Global Kidney Chip Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Kidney Chip Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Kidney Chip Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Kidney Chip Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Kidney Chip Consumption Value Market Share by Region in 2025
Figure 27. North America Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Kidney Chip Revenue Share by Players in 2025
Figure 34. Kidney Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Kidney Chip by Player Revenue in 2025
Figure 36. Top 3 Kidney Chip Players Market Share in 2025
Figure 37. Top 6 Kidney Chip Players Market Share in 2025
Figure 38. Global Kidney Chip Consumption Value Share by Type (2021-2026)
Figure 39. Global Kidney Chip Market Share Forecast by Type (2027-2032)
Figure 40. Global Kidney Chip Consumption Value Share by Application (2021-2026)
Figure 41. Global Kidney Chip Market Share Forecast by Application (2027-2032)
Figure 42. North America Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Kidney Chip Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Kidney Chip Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 52. France Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Kidney Chip Consumption Value Market Share by Region (2021-2032)
Figure 59. China Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 62. India Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Kidney Chip Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Kidney Chip Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 76. Kidney Chip Market Drivers
Figure 77. Kidney Chip Market Restraints
Figure 78. Kidney Chip Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Kidney Chip Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
Figure 1. Kidney Chip Picture
Figure 2. Global Kidney Chip Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Kidney Chip Consumption Value Market Share by Type in 2025
Figure 4. Glomerulus-on-a-Chip
Figure 5. Renal Tubule-on-a-Chip
Figure 6. Others
Figure 7. Global Kidney Chip Consumption Value by Channel, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Kidney Chip Consumption Value Market Share by Channel in 2025
Figure 9. Single-Channel
Figure 10. Dual-Channel
Figure 11. Global Kidney Chip Consumption Value by Source, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Kidney Chip Consumption Value Market Share by Source in 2025
Figure 13. Primary Human Cell-Based Type
Figure 14. Immortalized Cell Line-Based Type
Figure 15. Stem Cell & Organoid-Based Type
Figure 16. Global Kidney Chip Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Kidney Chip Consumption Value Market Share by Application in 2025
Figure 18. Hospitals Picture
Figure 19. Research Institutions Picture
Figure 20. Universities Picture
Figure 21. Others Picture
Figure 22. Global Kidney Chip Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Kidney Chip Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Kidney Chip Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Kidney Chip Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Kidney Chip Consumption Value Market Share by Region in 2025
Figure 27. North America Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Kidney Chip Revenue Share by Players in 2025
Figure 34. Kidney Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Kidney Chip by Player Revenue in 2025
Figure 36. Top 3 Kidney Chip Players Market Share in 2025
Figure 37. Top 6 Kidney Chip Players Market Share in 2025
Figure 38. Global Kidney Chip Consumption Value Share by Type (2021-2026)
Figure 39. Global Kidney Chip Market Share Forecast by Type (2027-2032)
Figure 40. Global Kidney Chip Consumption Value Share by Application (2021-2026)
Figure 41. Global Kidney Chip Market Share Forecast by Application (2027-2032)
Figure 42. North America Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Kidney Chip Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Kidney Chip Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 52. France Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Kidney Chip Consumption Value Market Share by Region (2021-2032)
Figure 59. China Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 62. India Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Kidney Chip Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Kidney Chip Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Kidney Chip Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Kidney Chip Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Kidney Chip Consumption Value (2021-2032) & (USD Million)
Figure 76. Kidney Chip Market Drivers
Figure 77. Kidney Chip Market Restraints
Figure 78. Kidney Chip Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Kidney Chip Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source